Feds push combo therapy treatments in LTC to combat new COVID variants … People connections buoyed elders during pandemic, investigators say … Task force pinpoints eldercare services that drive up...
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
By
Alicia Lasek
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
November’s drop in COVID deaths may hint at early nursing home success, experts contend
By
Alicia Lasek
Mar 16, 2021
Between spring pandemic lockdowns and November, mortality rates due to COVID-19 in nursing homes declined significantly — well before a vaccine was approved to treat the disease, according to a new study.
Clinical briefs for Tuesday, Aug. 3
By
Alicia Lasek
Aug 03, 2021
SNF recovery threatened by spread of delta variant: LTC exec … Nursing home COVID-19 outbreaks rising again in hot spots … Massachusetts outbreak prompts CDC to suggest re-upped pandemic mitigation...
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...